Primary research focus: metabolic pathway research involving triple incretin receptor activity, including GIP, GLP-1, and glucagon receptor models.

Retatrutide is commonly studied in laboratory settings for receptor signaling, energy balance, and metabolic research models.

Research use only. Not for human or veterinary use, consumption, diagnosis, treatment, or prevention.